FASN and nonpapillary renal cell carcinoma: Importantly, elevated FASN expression was significantly associated with poor PFS (HR = 1.854, p< 0.001) and OS (HR = 2.017, p< 0.001) of the 380 ccRCC patients in the FUSCC cohort.